Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,602,006
  • Shares Outstanding, K 110,268
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • 60-Month Beta 1.12
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.54
Trade VKTX with:

Options Overview Details

View History
  • Implied Volatility 106.39% ( +20.30%)
  • Historical Volatility 64.57%
  • IV Percentile 59%
  • IV Rank 45.28%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.34
  • Today's Volume 37,831
  • Volume Avg (30-Day) 20,271
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 182,737
  • Open Int (30-Day) 176,263

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.25
  • Number of Estimates 8
  • High Estimate -0.17
  • Low Estimate -0.31
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -31.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.64 +12.04%
on 04/19/24
81.86 -15.64%
on 05/07/24
+1.11 (+1.63%)
since 04/16/24
3-Month
34.04 +102.88%
on 02/21/24
99.41 -30.53%
on 02/28/24
+32.86 (+90.77%)
since 02/16/24
52-Week
8.28 +734.06%
on 10/26/23
99.41 -30.53%
on 02/28/24
+44.41 (+180.22%)
since 05/16/23

Most Recent Stories

More News
How Viking Therapeutics Stock Could 30x

This mid-cap biopharma may one day be a titan of the industry.

LLY : 771.12 (-2.02%)
NVO : 133.04 (-1.20%)
VKTX : 69.06 (-11.47%)
PFE : 28.92 (+0.35%)
Is Viking Therapeutics the Best Biotech Stock for You?

With good mid-stage results and plenty of cash, Viking could be a winner.

VKTX : 69.06 (-11.47%)
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?

The anti-obesity medication stock is way up, and there could be more fuel in the tank.

NVO : 133.04 (-1.20%)
VKTX : 69.06 (-11.47%)
LLY : 771.12 (-2.02%)
5 'Strong Buy' Growth Stocks to Grab This May

Growth stocks such as Viking Therapeutics, Cresco Labs, and Alphatec Holdings continue to trade at a significant discount to analysts' consensus price target estimates.

$SPX : 5,297.10 (-0.21%)
VKTX : 69.06 (-11.47%)
MS : 99.58 (-0.94%)
BTDR : 5.86 (+3.53%)
^BTCUSD : 65,605.71 (+0.54%)
ATEC : 11.43 (-0.35%)
CRLBF : 2.2200 (+6.22%)
CELH : 92.57 (-1.38%)
Is Viking Therapeutics Incredibly Undervalued?

The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.

PFE : 28.92 (+0.35%)
VKTX : 69.06 (-11.47%)
LLY : 771.12 (-2.02%)
NVO : 133.04 (-1.20%)
Can This High-Flying Stock 10x in 10 Years?

This midcap biotech could see huge success ahead -- or disappointment.

LLY : 771.12 (-2.02%)
VKTX : 69.06 (-11.47%)
1 Little-Known Vanguard Index Fund to Buy Before It Soars 50%, According to a Wall Street Analyst

Tom Lee of Fundstrat Global Advisors thinks the small-cap Russell 2000 could climb 50% by the end of 2024.

CME : 212.73 (+2.15%)
MORN : 299.97 (-0.22%)
MSTR : 1,439.98 (-4.22%)
LNW : 94.83 (+0.16%)
SMCI : 904.40 (-5.04%)
VKTX : 69.06 (-11.47%)
WFRD : 122.85 (-1.80%)
COMP : 4.35 (-1.36%)
JPM : 202.47 (+0.18%)
SSD : 169.56 (-3.48%)
FIX : 321.60 (-5.29%)
ELF : 162.26 (-3.60%)
3 Millionaire-Maker Biotech Stocks

The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.

IOVA : 10.43 (-2.34%)
RXRX : 9.51 (-5.00%)
VKTX : 69.06 (-11.47%)
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Good news could be just around the corner for two drugmakers not named Novo Nordisk.

CRSP : 55.67 (-2.26%)
LLY : 771.12 (-2.02%)
NVO : 133.04 (-1.20%)
VRTX : 440.64 (+0.72%)
VKTX : 69.06 (-11.47%)
Better Buy: Pfizer vs. Viking Therapeutics

These two pharma stocks have followed distinct paths of late. Which is the better investment?

LLY : 771.12 (-2.02%)
NVO : 133.04 (-1.20%)
NVDA : 943.59 (-0.29%)
AMGN : 314.72 (-1.35%)
PFE : 28.92 (+0.35%)
VKTX : 69.06 (-11.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 82.98
2nd Resistance Point 79.94
1st Resistance Point 74.50
Last Price 69.06
1st Support Level 66.01
2nd Support Level 62.96
3rd Support Level 57.52

See More

52-Week High 99.41
Last Price 69.06
Fibonacci 61.8% 64.60
Fibonacci 50% 53.85
Fibonacci 38.2% 43.09
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar